Brief: Atea Pharmaceuticals Reports Nonclinical Bemnifosbuvir (At-527) Toxicology Data
28/03/2022 15:10
March 28 (Reuters) - Atea Pharmaceuticals Inc AVIR.O :
* ATEA PHARMACEUTICALS REPORTS NONCLINICAL BEMNIFOSBUVIR
(AT-527)
TOXICOLOGY DATA AT SOCIETY OF TOXICOLOGY 61ST ANNUAL MEETING
Source text for Eikon: ID:nGNXbmRdGN
Further company coverage: AVIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM